Our findings align with previous studies showing that LGALS3BP is upregulated during viral infections such as HIV, herpesvirus, influenza A virus, vesicular stomatitis virus, and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), where it modulates antiviral immunity (15, 18, 19, 31, 32). Here, LGALS3BP is linked to viral infectious disease.